New program aims to bring High-Tech diabetes monitoring to more patients

NCT ID NCT07548372

Recruiting now Knowledge-focused Sponsor: Montefiore Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a program called SPARK-CGM that helps primary care clinics prescribe continuous glucose monitors (CGM) to people with diabetes. CGM devices track blood sugar in real-time, but they are underused in primary care. The program provides training, workflow support, and feedback to doctors and staff. Researchers will measure how quickly and often CGM prescriptions are made across 20,000 patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SPARK-CGM implementation strategy (workflow, training, feedback)
What this could lead to: If successful, this could make continuous glucose monitors more widely available in primary care, helping more people with diabetes manage their blood sugar better.
What could go wrong: This is an implementation study, not testing a new treatment. Success depends on clinic participation and may not apply to other healthcare systems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS

Contacts and locations

Locations

Montefiore Medical Group (MMG)
RECRUITING

The Bronx, New York, 10467, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.